EX-16.1 2 f161.htm LETTER FROM MOSS ADAMS LLP DATED MARCH 8, 2018 Converted by EDGARwiz

EXHIBIT 16.1




March 8, 2018



Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549-6561



Ladies and Gentlemen:



We have read Item 4.01 of Form 8-K dated March 8, 2018 of IASO BioMed, Inc. and are in agreement with the statements contained therein as they relate to our firm.


Respectfully,

/s/ Moss Adams LLP